StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

BioCorRx's gross profit for the twelve months ending Jun 30, 2025 was $313.14K, up 1625.6% year over year. For fiscal 2024 it was $6.00K, down 88.7% from the year before. Over ten years it grew -39.7% a year on average. The highest annual figure on record is $949.96K in fiscal 2014.

Annual gross profit

PeriodPeriod endValueChange
FY2024Dec 31, 2024$6.00K-88.7%
FY2023Dec 31, 2023$53.17K-73.2%
FY2022Dec 31, 2022$198.56K+368.4%
FY2021Dec 31, 2021$42.39K+58.9%
FY2020Dec 31, 2020$26.67K-83.2%
FY2019Dec 31, 2019$158.59K-22.9%
FY2018Dec 31, 2018$205.70K-38.4%
FY2017Dec 31, 2017$333.66K-36.6%
FY2016Dec 31, 2016$526.34K-31.9%
FY2015Dec 31, 2015$772.76K-18.7%
FY2014Dec 31, 2014$949.96K+71.2%
FY2013Dec 31, 2013$554.78K+19.1%
FY2012Dec 31, 2012$465.68K+25.4%
FY2011Dec 31, 2011$371.35K–
FY2010Dec 31, 2010-$11.82K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$57.00K–
Q1 FY2026Mar 31, 2026$189.36K–
Q2 FY2025Jun 30, 2025$178.24K+4306.4%
Q1 FY2025Mar 31, 2025$134.90K+6807.3%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$4.05K-56.3%
Q1 FY2024Mar 31, 2024$1.95K-93.9%
Q4 FY2023Dec 31, 2023$5.89K-69.0%
Q3 FY2023Sep 30, 2023$6.26K-71.2%
Q2 FY2023Jun 30, 2023$9.26K-2.5%
Q1 FY2023Mar 31, 2023$31.77K–
Q1 FY2022Mar 31, 2022$18.98K+43.2%
Q2 FY2021Sep 30, 2021$21.72K+251.1%
Q1 FY2021Mar 31, 2021$9.49K-32.0%
Q4 FY2020Dec 31, 2020-$6.73K-118.6%
Q3 FY2020Sep 30, 2020$13.26K-45.4%
Q2 FY2020Jun 30, 2020$6.19K-82.6%
Q1 FY2020Mar 31, 2020$13.96K-77.6%
Q4 FY2019Dec 31, 2019$36.26K–
Q3 FY2019Sep 30, 2019$24.27K-58.2%
Q2 FY2019Jun 30, 2019$35.61K-22.0%
Q1 FY2019Mar 31, 2019$62.45K-45.7%
Q4 FY2018Dec 31, 2018-$12.90K-132.8%
Q3 FY2018Sep 30, 2018$58.00K-58.4%
Q2 FY2018Jun 30, 2018$45.68K+4.1%
Q1 FY2018Mar 31, 2018$114.92K+3.6%
Q4 FY2017Dec 31, 2017$39.32K-39.3%
Q3 FY2017Sep 30, 2017$139.59K+7.4%
Q2 FY2017Jun 30, 2017$43.88K-69.0%
Q1 FY2017Mar 31, 2017$110.88K-41.6%
Q4 FY2016Dec 31, 2016$64.74K+6.7%
Q3 FY2016Sep 30, 2016$129.91K–
Q2 FY2016Jun 30, 2016$141.73K–
Q1 FY2016Mar 31, 2016$189.96K–
Q4 FY2015Dec 31, 2015$60.68K–

More BioCorRx figures

See a number that looks wrong?